Diem H - Search Results

1

Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy.

Bartl R, Frisch B, Diem H, Mündel M, Fateh-Moghadam A. Bartl R, et al. Among authors: diem h. Eur J Haematol Suppl. 1989;51:88-98. doi: 10.1111/j.1600-0609.1989.tb01499.x. Eur J Haematol Suppl. 1989. PMID: 2697597

2

Histologic, biochemical, and clinical parameters for monitoring multiple myeloma.

Bartl R, Frisch B, Diem H, Mündel M, Nagel D, Lamerz R, Fateh-Moghadam A. Bartl R, et al. Among authors: diem h. Cancer. 1991 Nov 15;68(10):2241-50. doi: 10.1002/1097-0142(19911115)68:10<2241::aid-cncr2820681024>3.0.co;2-0. Cancer. 1991. PMID: 1913461

3

Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase.

Diem H, Fateh-Moghadam A, Lamerz R. Diem H, et al. Clin Investig. 1993 Nov;71(11):918-23. doi: 10.1007/BF00185604. Clin Investig. 1993. PMID: 8312685

4

P-glycoprotein expression in patients with acute leukemia-clinical relevance.

Nüssler V, Pelka-Fleischer R, Zwierzina H, Nerl C, Beckert B, Gieseler F, Diem H, Ledderose G, Gullis E, Sauer H, Wilmanns W. Nüssler V, et al. Among authors: diem h. Leukemia. 1996 Jul;10 Suppl 3:S23-S31. Leukemia. 1996. PMID: 8656697

5

Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients.

Nuessler V, Gullis E, Pelka-Fleischer R, del Valle F, Diem H, Beyerlein S, Zwierzina H, Wilmanns W. Nuessler V, et al. Among authors: diem h. Ann Hematol. 1997 Jul-Aug;75(1-2):17-26. doi: 10.1007/s002770050307. Ann Hematol. 1997. PMID: 9322679

6

[Low platelet count without manifest disease].

Mezger J, Sandor P, Diem H. Mezger J, et al. Among authors: diem h. Internist (Berl). 1993 Apr;34(4):366-9. Internist (Berl). 1993. PMID: 8486480 German. No abstract available.

7

Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression.

Nüssler V, Gieseler F, Zwierzina H, Gullis E, Pelka-Fleischer R, Diem H, Abenhardt W, Schmitt R, Langenmayer I, Wohlrab A, Kolb HJ, Wilmanns W. Nüssler V, et al. Among authors: diem h. Ann Hematol. 1997 Feb;74(2):57-64. doi: 10.1007/s002770050258. Ann Hematol. 1997. PMID: 9063374

8

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).

Wendtner CM, Ritgen M, Schweighofer CD, Fingerle-Rowson G, Campe H, Jäger G, Eichhorst B, Busch R, Diem H, Engert A, Stilgenbauer S, Döhner H, Kneba M, Emmerich B, Hallek M; German CLL Study Group (GCLLSG). Wendtner CM, et al. Among authors: diem h. Leukemia. 2004 Jun;18(6):1093-101. doi: 10.1038/sj.leu.2403354. Leukemia. 2004. PMID: 15071604 Clinical Trial.

9

[Immunophenotyping in modern leukemia diagnosis].

Kern W, Diem H, Haferlach T. Kern W, et al. Among authors: diem h. Dtsch Med Wochenschr. 2005 Feb 4;130(5):215-9. doi: 10.1055/s-2005-837405. Dtsch Med Wochenschr. 2005. PMID: 15678390 Review. German. No abstract available.

10

Neonatal hemochromatosis: a rare cause of nonimmune hydrops fetalis and fetal anemia.

Wisser J, Schreiner M, Diem H, Roithmeier A. Wisser J, et al. Among authors: diem h. Fetal Diagn Ther. 1993 Jul-Aug;8(4):273-8. doi: 10.1159/000263839. Fetal Diagn Ther. 1993. PMID: 8260082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters